Renal (nefrogenny) anemia
Nefrogenny (renal) anemia - decrease in function of kidneys at a chronic renal failure leads to a lack of erythropoietin therefore the insufficient quantity of erythrocytes is developed. As a result there is a reduction of capability of blood to transfer enough oxygen.
Content |
- Main article: Diseases of kidneys
- Renal failure
- Dialysis
- Transplantation of a kidney
Associated disease at diseases of kidneys
Renal anemia is one of serious associated diseases of a renal failure and directly affects severity of an asthenic syndrome at patients, portability of physical activity, efficiency of intelligence and force of immunity. In process of development of a chronic disease of kidneys also anemia progresses. The reason – in falling of synthesis of erythropoietin, hormone of growth of erythrocytes, in the damaged nefrona. According to experts, renal anemia occurs in 90% of patients.
Prevention and treatment of anemia
Prevention and correction of anemia directly affects expressiveness of course of a chronic renal disease, increases efficiency of treatment and improves quality of life of the patient.
2018: Plans of an output to the market of the first Russian medicine
The main method of treatment and prevention of renal anemia is medicinal therapy by medicines on the basis of erythropoietin. As the most effective medicines for 2018 are considered created on the basis of a darbepoetin an alpha, but still Russian patients were forced to apply expensive drugs of foreign producers. However in 2018 the Russian company BIOCAD announced completion of clinical trials of the first domestic bioanalogue of a darbepoetin an alpha (BCD-066) which is intended for therapy of anemia at renal and oncological diseases. Investment volume into development was 400 million rubles. Medicine should go on sale at the end of 2018, and in 2021 the company intends to bring to the market own innovative development of medicine, new to pharmaceutical market, for treatment of anemia at patients with a renal failure. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |